Skip to content

Clinical trials

Phase 1/2 Carcinoma, Merkel Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Merkel Cell Phase: Phase 1/2 Country / region: Canada Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kartos Therapeutics, Inc.1
Marengo Therapeutics, Inc.1
Medicenna Therapeutics, Inc.1
Ocellaris Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Merkel Cell4
Neoplasms3
Stomach Neoplasms3
Urinary Bladder Neoplasms3
Uterine Cervical Neoplasms3
Basal Cell Carcinoma2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Endometrial Neoplasms2

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.